Exploration of Current and New Technologies for Accuracy of Diagnosing OSA
← catalyst calendarNCT07485582 · readout ≤ 72 d
Sponsored by ResMed (industry) · RMD — their whole pipeline →. With KlinEra Global Services.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
90estimated
Sites
5
Country
Australia
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Sep 2026 | estimated | When the study began enrolling |
| Primary completion | Oct 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Oct 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2026-03-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Obstructive Sleep Apnea
Interventions
- Device: Device A
- Device: Device B
- Device: Device C
- Device: Device D
- Device: Device E
- Diagnostic test: Screener A
Primary outcomes
what the primary-completion date above is the date OFSensitivity
measured Single night PSG
Specificity
measured A single night PSG
Permalink · RMD's whole pipeline · Catalyst calendar · Every registered study · What changed